Beijing Condor-Teco Medical Technology Co., Ltd.
[Beijing China (Mainland) ]
- 1st
- Business Type:
- Year Established:
- 0
- Total Revenue:
- Main Markets:
Company Description
Beijing Condor-Teco Medical Technology Co., Ltd., located in the Changping Science Park in China's capital city of Beijing, is a high-tech enterprise established in October 2002. Co-founded by Zhejiang Condor Holdings, Erdos Cashmere Group and Teco Diagnostic Co., Ltd., we have registered capital worth RMB22. 22 million. Specializing in the manufacture of chemical liquid and powder reagents, as well as urine reagent strips and readers, we also supply various other products in the diagnostic area. Furthermore, we have additionally begun to produce specific reagents matching biological and chemical equipment in recent years.
Boasting expert R&D, production, sales and customer service departments, we rank among the few rare enterprises meeting GMP standards in the Chinese diagnostic and reagent market. Utilizing multiple production lines integrating advanced equipment and research devices, all of our technologies meet the ISO13485 quality management standard, in addition to passing auditing under CE stipulations.
Specializing in urine reagent tests and urinalysis strips, we have obtained a number of independent intellectual property rights due to our qualified R&D team's unremitting efforts. Also cooperating with the National Academy of Medical Science under the State government's eleventh "Five Year Plan", we were made responsible for the R&D, application and promotion of portable urine analyzers.
A major player in the Chinese urinalysis market, we also export our products to clients around the world. In fact, our main overseas markets now include the UK, USA, Poland, India, Cameroon, Egypt, Yemen, Brazil, Chile and dozens of others countries. Using advanced diagnostic technology provided by Teco Diagnostic in the USA, combined with Condor Holdings' vast sales network and the Erdos Group's powerful brand image, we are deeply convinced that we will become a leader in the world medical diagnostic market.